Baseline characteristics of psoriasis patients participating in the VALUE multinational postmarketing observational study

被引：0
|
作者：
Thaci, Diamant [1 ]
Lynde, Charles [2 ]
Maul, Julia-Tatjana [3 ]
Szegedi, Andrea [4 ]
Ohtsuki, Mamitaro [5 ]
Wang, Hongwei [6 ]
Soliman, Ahmed M. [6 ]
Rubant, Simone [6 ]
Papp, Kim A. [7 ]
机构：
[1] Univ Lubeck, Inst & Comprehens Ctr Inflammat Med, Lubeck, Germany
[2] Lynde Inst, Dermatol & Prob Med Res, Markham, ON, Canada
[3] Univ Zurich Hosp, Dept Dermatol, Zurich, Switzerland
[4] Univ Debrecen, Fac Med, Dept Dermatol, Div Dermatol Allergol, Debrecen, Hungary
[5] Jichi Med Univ, Dept Dermatol, Shimotsuke, Tochigi, Japan
[6] AbbVie Inc, N Chicago, IL USA
[7] Clin Res & Prob Med Res, Waterloo, ON, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
25824
引用
收藏
页码：AB71 / AB71
页数：1
相关论文
共 50 条
  • [1] BASELINE MUSCULOSKELETAL SYMPTOMS IN PSORIASIS PATIENTS: A PROSPECTIVE OBSERVATIONAL STUDY
    Vivekanantham, Arani
    Bertheussen, Heidi
    Moncusi, Marta Pineda
    Fitzgerald, Oliver
    Pennington, Stephen
    Coates, Laura C.
    [J]. ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [2] STUDY DESIGN AND BASELINE CHARACTERISTICS OF THE POPULATION ENROLLED IN A MULTINATIONAL, OBSERVATIONAL STUDY OF TERIPARATIDE (ALAFOS)
    Chen, C. -H.
    Alsalmawy, A.
    Ish-Shalom, S.
    Lim, S. -J.
    Al-Ali, N.
    Cunha-Borges, J. L.
    Yang, H.
    Casas, N.
    Altan, L.
    Moll, T.
    Gurbuz, S.
    Brnabic, A. J. M.
    Marin, F.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S298 - S299
  • [3] STUDY DESIGN AND BASELINE CHARACTERISTICS OF THE POPULATION ENROLLED IN A MULTINATIONAL, OBSERVATIONAL STUDY OF TERIPARATIDE (ALAFOS)
    Chen, C. H.
    Alsalmawy, A.
    Ish-Shalom, S.
    Lim, S. -J.
    Al-Ali, N.
    Cunha-Borges, J.
    Yang, H.
    Casas, N.
    Altan, L.
    Moll, T.
    Gurbuz, S.
    Brnabic, A.
    Marin, F.
    Hassanzai, M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S85 - S86
  • [4] Baseline comorbid conditions of psoriasis patients participating in response, an observational study of long-term treatment with efalizumab and other biologic therapies
    Leonardi, Craig
    Hamilton, Tiffani
    Brodell, Robert
    Kircik, Leon
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB60 - AB60
  • [5] BASELINE CHARACTERISTICS OF THE PATIENTS PARTICIPATING IN THE HONEYPOT TRIAL
    Johnson, D. W.
    [J]. NEPHROLOGY, 2009, 14 : A23 - A23
  • [6] BASELINE CHARACTERISTICS OF THE PATIENTS PARTICIPATING IN THE FAVOURED TRIAL
    Irish, A.
    [J]. NEPHROLOGY, 2010, 15 : 35 - 35
  • [7] BASELINE CHARACTERISTICS OF THE PATIENTS PARTICIPATING IN THE FAVOURED TRIAL
    Irish, A.
    [J]. NEPHROLOGY, 2014, 19 : 19 - 19
  • [8] Study description and baseline characteristics of the population enrolled in a multinational observational study of extended teriparatide use (ExFOS)
    Ljunggren, O.
    Benhamou, C. L.
    Dekker, J.
    Kapetanos, G.
    Kocjan, T.
    Langdahl, B. L.
    Napoli, N.
    Petto, H.
    Nikolic, T.
    Lindh, E.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (08) : 1607 - 1616
  • [9] BASELINE CHARACTERISTICS IN PATIENTS INITIATING IXEKIZUMAB IN THE PSORIASIS SPECIAL AREAS (PSOSA) OBSERVATIONAL STUDY- FIRST INTERIM RESULTS
    Malatestinic, William N.
    Lewitt, George Michael
    Gill, Bartley Joseph
    Fernandez-Obregon, Adolfo
    Feely, Meghan
    Riya, Aisha Vadha-
    Malatestinic, William N.
    See, Kyoungah
    Zhu, Baojin
    Merola, Joseph F.
    [J]. ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [10] The IMPROVE™ study - a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts
    Valensi, P.
    Benroubi, M.
    Borzi, V.
    Gumprecht, J.
    Kawamori, R.
    Shaban, J.
    Shah, S.
    Shestakova, M.
    Wenying, Y.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (11) : 1809 - 1819
12345